Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/88—Polyamides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
  • A61Q19/08—Anti-ageing preparations
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/74—Biological properties of particular ingredients
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
  • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Definitions

• the present application relates to an anti-carbonylation composition including polylysine (s) , and further relates to a method of reducing and/or inhibiting protein carbonylation, particularly a method of protecting the tissues (for example, keratin materials, especially keratin fiber (s) , such as skin etc. ) from carbonylation stimuli, by using a composition including polylysine (s) .
• the skin is the body's first barrier against external environmental stimuli.
• the important mechanism of environmental pollutants such as particulate matter, ultraviolet rays, ozone and the like invading the skin is to attack the unsaturated lipids in the surface layer of the skin through oxidative damage, destroy the outermost protective layer of the skin, and produce active carbonyl substances, such as malondialdehyde, 4-Hydroxy nonenal, acrolein, etc..
• active carbonyl substances such as malondialdehyde, 4-Hydroxy nonenal, acrolein, etc.
• Protein carbonyls have been shown to be major products of protein oxidation, and may be formed via oxidative cleavage of proteins, direct oxidation of amino acid residues or covalent reaction with aldehydes derived from lipid peroxidation.
• protein carbonylation refers to the process in which the amino or imino groups in the side chain of amino acid residues are attacked by oxygen free radicals and finally converted into aldehyde groups and release NH3+, wherein the bond of the peptide is broken, and a carbonyl group is generated at the break, and the content of the carbonyl group is greatly increased after the amino acid of the protein side chain is attacked by hydroxyl free radicals and modified by oxidation.
• protein carbonylation occurs because of the direct metal-catalyzed oxidation of amino acid side chains (primary protein carbonylation) or the addition of reactive aldehydes to amino acid side chains (secondary protein carbonylation) .
• reactive aldehydes of exogenous origin such as acrolein, are well known to be derived from cigarette smoke.
• ROS reactive oxygen species
• carbonyl protein is a hallmark of carbonylation stress, e.g., as an extrinsic factor, such as that induced by ultraviolet radiation or an external application of oxidative chemicals, or as intrinsic factors, such as chemical attack by reactive carbonyls derived from the degradation of lipid peroxides.
• Carbonylated proteins in the skin mainly exist in the epidermis and dermis, and the content of carbonylated proteins in the epidermis is higher than that in the dermis. This is because the epidermis of the skin is continuously exposed to the oxidative environment and the unsaturated lipid environment secreted by the sebaceous glands, creating favorable conditions for the continuous generation of reactive aldehyde compounds.
• carbonyl stress causes skin damage, such as accelerated skin aging, or various pathological reactions of the skin.
• Protein carbonylation damages the skin's water-holding capacity, affects the skin's light transmittance, and changes the skin's optical properties etc..
• the presence of carbonylated proteins is associated with changes in skin characteristics: such as mechanical properties; water-holding capacity, including decreased moisture content and increased epidermal water loss; dull skin; and decreased skin clarity.
• increased levels of carbonylated proteins can lead to inflammatory skin diseases such as psoriasis and dermatitis.
• anti-carbonylation agents capable of inhibiting or preventing protein carbonylation
• skin care compositions and methods comprising anti-carbonylation agents to improve skin appearance or improve at least one sign of skin aging (such as decreased water-holding capacity, dull skin, skin yellowness, decreased skin clarity, elasticity, contrast, etc. ) and reduces the occurrence of inflammatory skin diseases such as psoriasis and dermatitis.
• the present application is directed to cosmetic compositions comprising at least one polylysine. This present application is also directed to methods for reducing or inhibiting protein carbonylation on keratin materials, especially the skin.
• topical application it meant that the composition is applied or spread onto the surface of the keratin materials, such as at least one zone of the skin.
• anti-carbonylation means reducing and/or inhibiting protein carbonylation, particularly protecting the tissues (for example, keratin materials, especially keratin fiber (s) , such as skin etc. ) from carbonylation stimuli.
• polylysine means lysine–based polymer (s) .
• the present anti-carbonylation composition (or agent) comprising (or consisting of) at least one polylysine can achieve improved anti-carbonylation efficacy.
• the present application is directed to the present anti-carbonylation composition (or agent) comprising (or consisting of) at least one polylysine as cosmetic compositions.
• This present application is also directed to methods for reducing and/or inhibiting protein carbonylation on keratin materials, especially the keratin fiber (s) , such as skin, by applying the compositions comprising the present anti-carbonylation composition (or agent) comprising (or consisting of) at least one polylysine.
• the polylysine preferably is L-lysine based polymers.
• the polylysine may be selected from the group consisting of linear ⁇ -polylysine, linear ⁇ -polylysine, hyperbranched polylysine or dendritic polylysine.
• the polylysine preferably is the ⁇ -polylysine and/or dendritic polylysine
• the polylysine has the molecular weight of more than 200, even more than 300, or more than 400, preferably more than 500, or more than 800.
• the polylysine has the molecular weight of less than 200000, even less than 150000, or less than 100000, preferably less than 50000, or less than 20000.
• the polylysine has the molecular weight of between 200 and 200000, even between 400 and 100000, or between 600 and 50000, or between 800 and 20000, or between 1000 and 15000, preferably between 1000 and 10000.
• a preferred molecular weight of the ⁇ -polylysine is lower than 30000.
• the polylysines are present in the cosmetic composition from 0.0001%to 10%by weight, preferably from 0.001%to 5%by weight, preferably from 0.001%to 2%by weight, relative to the total weight of the composition.
• the present composition further comprises a functional agent, which may be, such as, at least one active agent such as skin care agent (s) , selected from the group consisting of moisturising agents, such as protein hydrolysates, and polyols, such as glycerol, glycols, polyethylene glycols, and sugar derivatives; natural extracts; vitamins, such as vitamin A (retinol) , vitamin E (tocopherol) , vitamin C (ascorbic acid) , vitamin B5 (panthenol) , vitamin B3 (niacinamide) , the derivatives of these vitamins (in particular esters) and their mixtures; urea; caffeine; salicylic acid and its derivatives; alpha-hydroxy acids, such as lactic acid and glycolic acid, and their derivatives; retinoids, such as carotenoid and vitamin A derivatives; sunscreen; essential oils of mint, aloe vera or ginseng and their mixtures.
• skin care agent selected from the group consisting of moisturising agents,
• Another subject of the present application is to provide a process of preparing the anti-carbonylation composition, comprising the following steps:
• Another subject of the present application is to provide a non-therapy cosmetic method for countering denaturation of keratin materials, especially the skin, by applying the present composition.
• Another subject of the present application is to provide a non-therapy cosmetic method for caring for keratin materials, especially the skin, by applying the present anti-carbonylation composition.
• Another subject of the present application relates to a use of the present composition or preparing a product of caring for keratin materials, especially the skin.
• Another subject of the present application is to provide a cosmetic product, comprising the present composition.
• Polylysines refer to several types of lysine-based homopolymers, which may differ from each other in terms of stereochemistry and link position.
• Lysine an essential amino acid for humans
• L-lysine and D-lysine Polymerization of specific chiral lysine monomer will result in L-polylysine and D-polylysine respectively.
• the precursor amino acid lysine contains two amino groups, one at the ⁇ -carbon and one at the ⁇ -carbon. Either can be the location of polymerization, resulting in ⁇ -polylysine or ⁇ -polylysine.
• Polylysine can further be classified according the topology of the polymer chain into linear, hyperbranched and dendritic polylysine. The molecular weight of polylysine can range from 100-1000000.
• Polylysines in this application, refers to lysine-based polymers, such as linear ⁇ -polylysine ( ⁇ -PL) , linear ⁇ -polylysine ( ⁇ -PL) , hyperbranched polylysine and dendritic polylysines.
• ⁇ -PL linear ⁇ -polylysine
• ⁇ -PL linear ⁇ -polylysine
• ⁇ -PL hyperbranched polylysine
• dendritic polylysines dendritic polylysines
• polylysines are present in the topical composition at the following concentrations: 0.0001%to 10%by weight, preferably from 0.001%to 5%by weight, preferably from 0.001%to 2%by weight, relative to the total weight of the composition.
• the polylysine outperformed monomeric lysine in anti-carbonylation efficacy, optionally with its concentration, for example, ranging from 0.005%to 0.05%, without wishing to be bound by theory, which could possibly contribute to the “multivalent effect” of the polymeric chain.
• the polylysine is preferably selected from the ⁇ -polylysine and/or dendritic polylysine.
• the products of the present application may comprise at least one functional agent, such as, at least one active agent, for example, selected from the group consisting of: desquamating or moisturizing agents; depigmenting or anti-depigmenting agents; anti-glycation agents; anti-NO agents; agents for stimulating the synthesis of dermal or epidermal macromolecules and/or for preventing their degradation; agents for stimulating fibroblast or keratinocyte proliferation and/or keratinocyte differentiation; muscle relaxants or dermo-decontracting agents; free-radical scavengers or anti-pollution agents; tensioning agents; agents acting on the capillary circulation; certainly, the following particularly active agents, and mixtures thereof.
• at least one active agent for example, selected from the group consisting of: desquamating or moisturizing agents; depigmenting or anti-depigmenting agents; anti-glycation agents; anti-NO agents; agents for stimulating the synthesis of dermal or epidermal macromolecules and/or for preventing their degradation;
• ⁇ -or ⁇ -hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, ⁇ -hydroxydecanoic acid, ⁇ -hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, ⁇ -hydroxybutyric acid, ⁇ -hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic acid.
• ⁇ -or ⁇ -hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, ⁇ -hydroxydecanoic acid, ⁇ -hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, ⁇ -hydroxybutyric acid, ⁇ -hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic acid.
• anti-acne agents such as salicylic acid or benzoyl peroxide, octopirox, dextrorotary and levorotary sulfur-containing amino acids, their salts, and their N-acetyl derivatives such as N-acetyl cysteine, or agents seeking to prevent aging of the skin and/or to improve its state, for example the above-mentioned ⁇ -and ⁇ -hydroxy acids, retinoids such as retinoic acid, retinol, and its esters, such as, for example, retinyl propionate, and retinyl acetate, or retinyl palmitate, niacinamide, allantoin, extracts of aloe, azelaic acid, bisabolol, phytic acid, collagen, or agents stimulating the formation of collagen, vitamins such as vitamin C or derivatives thereof, such as ascorbyl glucoside, vitamin E or derivatives thereof, vitamin A or derivatives thereof, vitamin F or
• active agents for improving the condition of the skin in the case of mask, such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof.
• active agents for improving the condition of the skin such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof.
• enzymes that have activity on the skin such as proteases, lipases, cerebrosidases, and/or melanases, and mixtures thereof.
• active agents that can be suitable for implementing the present application there are agents for drugs, peptides, proteins, detectable labels, contrast reagents, pain-killing, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermititis agents, anti-pruritic agents, anti-emetics, vascular protectors, agents against motion sickness, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratolytic agents, agents for treating dry skin, antiperspirants, anti-psoriatic agents, antidandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreen agents, antihistamines, healing agents, corticosteroids, tanning agents, and mixtures thereof.
• the content of the at least one active agent in the composition may be adjusted as a function of the intended purpose of the composition.
• composition of the present application may also contain adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
• adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
• This assay provides an in vitro method to determine how an anti-carbonylation agent/composition affects the extent of protein carbonylation.
• the anti-carbonylation agent/composition to be tested was made into a 1%solution
• Bovine Serum Albumin (BSA) was made into a 10 mg/mL solution
• Acrolein was made into a 10 mM solution.
• BSA bovine Serum Albumin
• Acrolein was made into a 10 mM solution.
• the sample containing only BSA and PBS served as a baseline, and the sample containing BSA, Acrolein and PBS served as a blank.
• the final liquid volume in each centrifuge tube was 1.0 mL. Each group contained three replicate samples, and all samples were placed at 37°C overnight.
• Dendritic PL is DENDIRCLEAR from Lucas Meyer.
• the protein carbonyl content in the above samples was detected by using the Protein Carbonyl Assay Kit of Nanjing Jiancheng Bioengineering Institute.
• the detection methods are as follows: take 0.1 mL of sample into the assay tube, then add 0.4 mL of reagent 3 in the kit, vortex to mix for 1 min, and react at 37°C for 30 min in the dark. Add 0.5 mL of reagent 5 in the kit, vortex and mix for 1 min, centrifuge at 12,000 r/min for 10 min at 4°C, discard the supernatant, and leave the pellet.
• BSA Diluted Albumin
• the corrected absorbance value is the absorbance value of the blank sample subtracted from the readings of each standard and sample.
• the protein concentration was read against a standard curve prepared with known amounts of BSA. Referring to the standard curve, according to the corrected absorbance value of each protein sample, read the protein concentration of each sample within the linear range of the standard curve. Calculate the amount of protein in the original sample based on the sample volume and dilution.
• each anti-carbonylation agent/composition can be obtained by dividing the carbonylation degree of the sample by the BSA protein content. The results are shown in the Table 2 and Table 3 below.
• the polylysine reduces and/or inhibits the protein carbonylation as shown above.
• composition of the invention containing polylysine is prepared by thoroughly mixing these ingredients as follows.
• compositions 1 to 4 were evaluated after applying them to the skin, and are summarized in the table below:
• compositions 1 to 4 were good, especially in terms of spreading, softness and non-stickiness.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Dermatology (AREA)
• Gerontology & Geriatric Medicine (AREA)
• Birds (AREA)
• Epidemiology (AREA)
• Cosmetics (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Applications Claiming Priority (1)

Publications (2)

Family

ID=89848187

Family Applications (1)

Country Status (9)

Families Citing this family (2)

Family Cites Families (14)

• 2022
  • 2022-08-04 AU AU2022473050A patent/AU2022473050A1/en active Pending
  • 2022-08-04 JP JP2025505938A patent/JP2025525187A/ja active Pending
  • 2022-08-04 CN CN202280100483.5A patent/CN119947698A/zh active Pending
  • 2022-08-04 US US19/100,524 patent/US20260000601A1/en active Pending
  • 2022-08-04 WO PCT/CN2022/110203 patent/WO2024026766A1/en not_active Ceased
  • 2022-08-04 KR KR1020257006419A patent/KR20250044369A/ko active Pending
  • 2022-08-04 CA CA3263648A patent/CA3263648A1/en active Pending
  • 2022-08-04 EP EP22953575.2A patent/EP4565201A4/de active Pending
• 2023
  • 2023-07-28 TW TW112128308A patent/TW202406532A/zh unknown

Also Published As

Similar Documents

Legal Events